YBX1 and glioblastoma: Our study indicates that by inhibiting DARS1-AS1, GBM cells/GSCs become more sensitive to ionizing radiation, which implies that targeting the DARS1-AS1/YBX1 axis could potentially make GBM more susceptible to radiation therapy.